Clinical trial
D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for…
NCT00257361 · University of Florida, Other · Withdrawn
Key facts
| NCT number | NCT00257361 |
|---|---|
| Title | D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder |
| Official title | D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder |
| Lead sponsor | University of Florida, Other |
| Collaborators | Obsessive Compulsive Foundation |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obsessive Compulsive Disorder |
| Intervention type | Drug |
| Interventions | D-Cycloserine |
| Enrollment | 0 |
| Start date | Jul 1, 2005 |
| First posted | Nov 22, 2005 |
| Last update posted | Sep 30, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: